Monopar Announces MNPR-101 Radiopharma Collaboration Agreement with National University of Singapore

WILMETTE, Ill., July 11, 2023 -- Monopar Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer, today announced a collaboration with...

Related Keywords

National University Of Singapore ,Singapore General ,Singapore ,United States ,United Kingdom ,Anand Jeyasekharan ,Kimr Tsuchimoto ,Chandler Robinson ,Ministry Of Education ,Exchange Commission ,Cancer Science Institute Of Singapore ,Linkedin ,National Research Foundation ,Twitter ,Monopar Therapeutics Inc ,Research Centres Of Excellence ,Nasdaq ,Cancer Science Institute ,National University ,Plasminogen Activator Receptor ,Principal Investigator ,Research Centres ,Private Securities Litigation Reform Act ,